New cancer drugs approved for NHS use in Scotland

13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...

Read more →

SMC - May 2019 decisions

13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Life-changing drug for chronic migraine approved in Scotland

8 April 2019 - The Scottish Medicines Consortium (SMC) announced that Aimovig (erenumab) has been accepted for adults who have ...

Read more →

SMC - April 2019 decisions

8 April 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

Keeping up the PACE at the Scottish Medicines Consortium

26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...

Read more →

SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma

11 March 2019 - Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS ...

Read more →

SMC - March 2019 decisions

11 March 2019 - The Scottish Medicines Consortium has today published advice accepting two new medicines. ...

Read more →

Yescarta rejected among other SMC decisions

12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...

Read more →

SMC - February 2019 decisions

11 February 2019 - A medicine used to treat a rare blood cancer in children and young adults has today  ...

Read more →

Life-extending drug Perjeta approved for secondary breast cancer

14 January 2019 - A drug used to treat advanced breast cancer has been approved for use on the NHS ...

Read more →

SMC - January 2019 decisions

14 January 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Perjeta given green light in Scotland as early stage breast cancer treatment

10 December 2018 - Hundreds of breast cancer patients are expected to benefit after a sought-after drug was approved for ...

Read more →

SMC - December 2018 decisions

10 December 2018 - A medicine used to treat early stage breast cancer has been accepted by the SMC for ...

Read more →

SMC - November 2018 decisions

12 November 2018 - A medicine used to treat a rare cancer which occurs predominantly in very young children has ...

Read more →

Revised process for ultra-orphan medicines

8 October 2018 - Following the Scottish Government's announcement around a new pathway in June 2018, a new approach to the ...

Read more →